Literature DB >> 16613575

Towards the targeted therapy of melanoma.

K S M Smalley1, M Herlyn.   

Abstract

Novel anti-cancer treatments use knowledge about the underlying biology of the tumor to find suitable molecular targets. The recent years have seen great advances in understanding the biology of melanoma. In the current review we discuss the most promising molecular targets for melanoma and suggest possible strategies for overcoming resistance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16613575     DOI: 10.2174/138955706776361402

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  11 in total

1.  Targeting sphingosine kinase-1 to inhibit melanoma.

Authors:  SubbaRao V Madhunapantula; Jeremy Hengst; Raghavendra Gowda; Todd E Fox; Jong K Yun; Gavin P Robertson
Journal:  Pigment Cell Melanoma Res       Date:  2012-03       Impact factor: 4.693

2.  Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1.

Authors:  Salvador Mena; María L Rodriguez; Angel Ortega; Sonia Priego; Elena Obrador; Miguel Asensi; Ignacio Petschen; Miguel Cerdá; Bob D Brown; José M Estrela
Journal:  J Transl Med       Date:  2012-01-10       Impact factor: 5.531

3.  Zinc oxide nanoparticles induce apoptosis and autophagy in human ovarian cancer cells.

Authors:  Ding-Ping Bai; Xi-Feng Zhang; Guo-Liang Zhang; Yi-Fan Huang; Sangiliyandi Gurunathan
Journal:  Int J Nanomedicine       Date:  2017-09-05

4.  Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells.

Authors:  Sanjay Singh
Journal:  Int J Nanomedicine       Date:  2018-03-15

Review 5.  Impact of nanoparticles on neuron biology: current research trends.

Authors:  Firdos Alam Khan; Dana Almohazey; Munthar Alomari; Sarah Ameen Almofty
Journal:  Int J Nanomedicine       Date:  2018-05-09

Review 6.  ZnO Nanoparticles: A Promising Anticancer Agent.

Authors:  Gunjan Bisht; Sagar Rayamajhi
Journal:  Nanobiomedicine (Rij)       Date:  2016-01-01

7.  Extracts of Clove (Syzygium aromaticum) Potentiate FMSP-Nanoparticles Induced Cell Death in MCF-7 Cells.

Authors:  Firdos Alam Khan; Sultan Akhtar; Dana Almohazey; Munthar Alomari; Sarah Ameen Almofty
Journal:  Int J Biomater       Date:  2018-08-23

8.  Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer Therapy.

Authors:  Raghavendra Gowda; Nathan R Jones; Shubhadeep Banerjee; Gavin P Robertson
Journal:  J Nanomed Nanotechnol       Date:  2013-12

9.  Chitosan-based thermoreversible hydrogel as an in vitro tumor microenvironment for testing breast cancer therapies.

Authors:  Ching-Ting Tsao; Forrest M Kievit; Kui Wang; Ariane E Erickson; Richard G Ellenbogen; Miqin Zhang
Journal:  Mol Pharm       Date:  2014-05-15       Impact factor: 4.939

10.  Registered Report: COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.

Authors:  Vidhu Sharma; Lisa Young; Miguel Cavadas; Kate Owen
Journal:  Elife       Date:  2016-03-21       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.